Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/19504
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSenchenkova, EY-
dc.contributor.authorRussell, J-
dc.contributor.authorVital, SA-
dc.contributor.authorYildirim, A-
dc.contributor.authorOrr, AW-
dc.contributor.authorGranger, DN-
dc.contributor.authorGavins, FNE-
dc.date.accessioned2019-11-06T11:25:18Z-
dc.date.available2018-06-
dc.date.available2019-11-06T11:25:18Z-
dc.date.issued2018-05-30-
dc.identifier.citationThe FASEB Journal, 2018, 32 (6), pp. 3448 - 3456en_US
dc.identifier.issn0892-6638-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/19504-
dc.format.extent3448 - 3456-
dc.language.isoenen_US
dc.publisherFederation of American Society of Experimental Biologyen_US
dc.subjectsCD40L thrombosisen_US
dc.subjectleukocytesen_US
dc.subjectplateletsen_US
dc.subjectendotheliumen_US
dc.subjecthypertensionen_US
dc.titleA critical role for both CD40 and VLA5 in angiotensin II–mediated thrombosis and inflammationen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1096/fj.201701068r-
dc.relation.isPartOfThe FASEB Journal-
pubs.issue6-
pubs.publication-statusPublished-
pubs.volume32-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdf1.7 MBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.